Xavier Trinidad Reveles
CIK: 0001993507
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BIAF
bioAffinity Technologies, Inc.
Officer
Discretionary Trading P&L
Holdings
About Reveles Xavier Trinidad
Reveles Xavier Trinidad (SEC CIK 0001993507) files insider reports with the SEC as Chief Operating Officer of bioAffinity Technologies, Inc. (BIAF).
Signal8 holds 1 ownership filing by Reveles Xavier Trinidad, a Form 4, filed on Jan 14, 2025. Those filings report 1 transaction, the latest on Jan 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Reveles Xavier Trinidad's filings is in SAN ANTONIO,, TX.
Recent filings by Reveles Xavier Trinidad
- Jan 10, 2025: Grant or award of BIAF shares (Form 4, code A).
Other insiders filing for bioAffinity Technologies, Inc. (BIAF)
- Rios Roberto, Director
- Oppenheimer John J., Director
- GIRGENTI STEVEN, Executive Chairman
- Zannes Maria, President & CEO
- Edwards James Michael, VP and CFO
- Zannes Timothy P, Secretary, EVP, Gen. Counsel